|
|
Vol. 15.21 – 05 November, 2026
|
|
|
|
|
|
|
|
|
Investigators showed that methyltransferase-like protein 13-catalyzed dimethylation of the elongation factor eukaryotic translation elongation factor 1α (eEF1A) at lysine 55 enhances decoding of select codons, preferentially increasing pro-oncogenic protein synthesis to promote tumorigenesis. [Nature Cell Biology]
|
|
|
|
|
|
PUBLICATIONSListed by the impact factor of the journal
|
|
|
|
|
|
Researchers identified the pulmonary disease-associated ATP-binding cassette transporter A3, a regulator of surfactant lipid accumulation, as a vesicle-associated membrane protein-associated protein A (VAPA) interactor.
[Developmental Cell]
|
|
|
|
|
|
By combining realistic long-term atmospheric aging with direct comparison of fresh and aged particles, scientists provided a uniquely controlled framework to assess how chemical aging reshapes epithelial stress and immune responses.
[Environmental Science & Technology]
|
|
|
|
|
|
Using comparative cigarette smoke (CS) exposure in neonatal and adult mice, investigators showed that early‑life CS produces fundamentally different pathology from adult exposure.
[Ecotoxicology and Environmental Safety]
|
|
|
|
|
|
The authors investigated the role of the forkhead box M1 (FOXM1)/long noncoding RNA (lncRNA) COPD-R axis in biomass-related particulate matter (PM)2.5-induced pulmonary inflammatory responses.
[Ecotoxicology and Environmental Safety]
|
|
|
|
|
|
Scientists investigated the role of AAA+ ATPase p97 in regulating sirtuin 1 (SIRT1) post-translational modification and its contribution to pulmonary pathology.
[Biochemical Pharmacology]
|
|
|
|
|
|
Researchers identified a novel circular RNA, designated as circDNA-Damage-Regulator-by-cadmium (DDRC), and demonstrated its significant association with DNA damage through integrated analyses of occupational cohorts, in vivo animal models, and in vitro cellular assays.
[Chemico-Biological Interactions]
|
|
|
|
|
|
|
|
The authors intended to examine the role of glycolysis in LUAD growth and immunosuppression and to explore the underpinning mechanisms.
[Journal for Immunotherapy of Cancer]
|
|
|
|
|
|
Scientists investigated the clinical relevance, regulatory mechanisms, and therapeutic potential of glucose metabolism in smoking-associated NSCLC.
[Cancer Letters]
|
|
|
|
|
|
Researchers observed the antitumor effect of osimertinib combined with the IGF1R inhibitor β-elemene in two EGFR mutant cell lines, both harboring AXL-low expression, and an orthotopic NSCLC nude mouse model.
[European Journal of Pharmacology]
|
|
|
|
|
|
Scientists aimed to investigate the role of 13β,21-dihydroeurycomanone (DHEN) in the pyroptosis of LUAD cells and found that DHEN significantly inhibited the proliferation of two LUAD cell lines, but had no obvious cytotoxic effects on normal human bronchial epithelial cells. [European Journal of Pharmacology]
|
|
|
|
|
|
|
|
The authors critically examine the evolving portfolio of delta-like ligand 3 (DLL3)-targeted therapies, a ligand aberrantly overexpressed on the surface of SCLC tumor cells, across three principal modalities.
[Cancer Treatment Reviews]
|
|
|
|
|
|
Investigators synthesize clinical evidence on the efficacy of immune checkpoint inhibition, currently the most widely used immunotherapy, in lung cancer patients concomitant with COPD and elucidate potential immunological and molecular mechanisms underlying observed clinical benefits.
[Cancer Letters]
|
|
|
|
|
|
The authors systematically summarize recent advances in proteolysis-targeting chimera (PROTAC) technology for lung cancer, emphasizing its efficacy against key oncogenic drivers and reactivating apoptosis. [Chinese Medical Journal]
|
|
|
|
|
|
|
|
Merck announced the initiation of ENHANCE-3, a Phase III randomized clinical trial evaluating OHTUVAYRE (ensifentrine) for the prevention of COPD exacerbations in adult patients receiving standard of care with a history of exacerbations. [Merck]
|
|
|
|
|
|
|
|
December 8-10, 2026 La Jolla, California, United States
|
|
|
|
|
|
|
|
|
|
|
Howard Hughes Medical Institute – Ashburn, Virginia, United States
|
|
|
|
|
|
|
Baylor College of Medicine – Houston, Texas, United States
|
|
|
|
|
|
|
The Icahn School of Medicine at Mount Sinai – New York City, New York, United States
|
|
|
|
|
|
|
University of California Los Angeles – Los Angeles, California, United States
|
|
|
|
|
|
|
Human Technopole – Milan, Italy
|
|
|
|
|
|